Special notice
Quantification of Drugs of Abuse and Related Compounds in Biological Specimens (Notice of Intent - Sole Source Modification)
75N95019C00016
National Institutes of Health, National Institutes of Health Nida. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Awarded
-$51,317.41 obligated so far on USAspending
Description
As published on SAM.gov.
NOTICE OF INTENT – SOLE SOURCE MODIFICATION This is a notice of intent to award a sole source modification under current Contract No. 75N95019C00016 (NIDA Ref. No. N01DA-19-8951) for the “Quantification of Drugs of Abuse and Related Compounds in Biological Specimens” with Utah University (Contractor).
The purpose of this sole source modification is to modify the Options to Extend the Period of Performance to establish two (2) additional three (3)-month Option Periods allowing for an ultimate Period of Performance through September 13, 2024, if all Options are exercised. This notice is being published by NIH/NIDA in accordance with Federal Acquisition Regulation (FAR) 5.2. The statutory authority for this sole source modification is FAR 6.302-1, Only One Responsible Source.
This notice of intent is not a request for competitive proposals. However, the Government shall consider all responses received within fifteen days of this posting. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely at the discretion of the Government.
Written responses to this synopsis shall contain sufficient documentation to establish a bona fide capability to fulfill this requirement. NIDA will not be responsible for any costs incurred by interested parties responding to this notice.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- University of Utah
- UEI
- LL8GLEVH6MG3
- CAGE
- 3T624
- Vendor location
- Salt Lake City, UT
- Contract
- 75N95019C00016, definitive contract
- Obligated
- -$51,317.41, current value $1,240,919, potential $1,248,641
- Actions
- 2 between March 4, 2024 and June 1, 2026
- Competition
- Full and Open Competition, 4 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- Quantification of Drugs of Abuse and Related Substances in Biological Specimens. Pop: March 14, 2019 Through June 13, 2024. N01DA-19-8951
- Match
- solicitation number 75N95019C00016 was reused as the contract number; same awarding office 75N950 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Robert Baileyrob.bailey@nih.gov3014517586
- Josh Lazarusjosh.lazarus@nih.gov3018276923
Also open from this buyer
- Account Management, Planning, and Maintenance for Online Crowd-Sourced Surveys and Cognitive Tasks for IndividualsCombined synopsis and solicitationNAICS 541990Bethesda, MD75N98026Q01128Closes in 4 daysSep 21
- CTN Data, Statistics, and Clinical Trial Support Center (DSC7)Sources soughtSmall businessNAICS 54171575N98026R00157SBCloses in 13 daysSep 30
- CTN Data, Statistics, and Clinical Trial Support Center (DSC7)Sources soughtNAICS 54171575N98026R00157OTCloses in 13 daysSep 30
- Data Access ProgramPresolicitationNAICS 54161175N95026R00003Closes in 104 daysDec 30